Skip to main content
Micro-Tech (Nanjing) Co.,Ltd logo

Micro-Tech (Nanjing) Co.,Ltd — Investor Relations & Filings

Ticker · 688029 ISIN · CNE100003MG1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2021-07-19 Legal Proceedings Report
Country CN China
Listing Shanghai Stock Exchange 688029

About Micro-Tech (Nanjing) Co.,Ltd

https://www.micro-tech.com.cn/

Micro-Tech (Nanjing) Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical devices. The company focuses on providing advanced solutions for gastroenterology, respiratory medicine, and orthopedics. Its product portfolio includes a wide range of endoscopic diagnostic and therapeutic tools such as biopsy forceps, disposable hemoclips, biliary and esophageal stents, and specialized instruments for Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Micro-Tech emphasizes innovation and quality, maintaining international certifications to serve a global healthcare market. By integrating precision engineering with clinical needs, the company aims to improve patient outcomes and procedural efficiency for medical professionals worldwide.

Recent filings

Filing Released Lang Actions
南微医学科技股份有限公司关于德国子公司涉及专利诉讼的公告
Legal Proceedings Report Classification · 95% confidence The document is a detailed announcement regarding a patent infringement lawsuit involving the company's German subsidiary. It includes information about the litigation parties, claims, potential financial impact, and ongoing legal strategy. The content focuses on legal proceedings and their implications rather than financial results, management changes, or shareholder votes. It is not a full audit report or annual/interim financial report. The document is not a brief announcement but a substantive legal update. Therefore, it fits best under the category of Legal Proceedings Report (LTR).
2021-07-19 Chinese
南微医学科技股份有限公司首次公开发行战略配售限售股上市流通公告
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement regarding the listing and circulation of restricted shares (strategic placement shares) following the company's initial public offering (IPO). It details the number of shares becoming tradable after the lock-up period, the type of shares, the lock-up duration, and confirms compliance with regulatory requirements. It includes a verification opinion from the sponsoring securities firm and references regulatory approvals. The document is not a financial report, earnings release, or management discussion, but rather a formal notice about the unlocking and circulation of restricted shares. This fits the category of Share Issue/Capital Change announcements, specifically about restricted shares becoming tradable after a lock-up period.
2021-07-13 Chinese
南京证券股份有限公司关于南微医学科技股份有限公司首次公开发行战略配售限售股上市流通的核查意见
Regulatory Filings Classification · 95% confidence The document is a verification opinion from the sponsoring institution (南京证券股份有限公司) regarding the listing and circulation of restricted shares from the initial public offering (IPO) of 南微医学科技股份有限公司. It details the type of shares, the lock-up period, shareholder commitments, and confirms compliance with relevant laws and regulations. The document does not contain financial statements or detailed financial data but is an official announcement related to the listing of restricted shares and their circulation. This fits the category of a Regulatory Filing (RNS) as it is a compliance and verification announcement rather than a full financial report or a capital change announcement (which would require more direct capital structure changes like new share issues). The document length is short (1606 characters), and it is a formal regulatory compliance statement.
2021-07-13 Chinese
南微医学科技股份有限公司关于德国专利诉讼进展的公告
Legal Proceedings Report Classification · 95% confidence The document is an announcement regarding the progress of a patent litigation case involving the company and its subsidiaries. It details the litigation stages, court judgments, potential financial impact, and legal strategies. The content is focused on legal proceedings and their implications for the company, without presenting financial statements or management analysis. It is not a full annual or interim report, nor an earnings release or investor presentation. The document is a regulatory announcement about ongoing legal matters, fitting the category of Legal Proceedings Report.
2021-06-20 Chinese
南微医学科技股份有限公司董事、高级管理人员集中竞价减持股份结果公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the results of share reduction by company directors and senior management through centralized bidding. It details the shareholding before and after the reduction, the number of shares reduced, the price range, and confirms the completion of the reduction plan. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives. The document is not a financial report, regulatory filing, or any other category. Therefore, the correct classification is DIRS.
2021-05-26 Chinese
南微医学科技股份有限公司高级管理人员减持股份进展公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the progress of share reduction by a senior management personnel (芮晨为) of the company 南微医学科技股份有限公司. It details the number of shares held before and after the reduction, the percentage of total shares, the method of reduction (concentrated bidding), and compliance with relevant laws and regulations. There is no financial data, no discussion of company financial performance, no meeting materials, no voting results, and no legal proceedings. The document is a regulatory disclosure about insider share transactions by a senior executive. This fits the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is short and focused solely on this insider share reduction progress, confirming it is not a full report or announcement of a report publication.
2021-05-25 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.